0001209191-23-050226.txt : 20230920
0001209191-23-050226.hdr.sgml : 20230920
20230920201117
ACCESSION NUMBER: 0001209191-23-050226
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230919
FILED AS OF DATE: 20230920
DATE AS OF CHANGE: 20230920
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WHITFIELD ROY A
CENTRAL INDEX KEY: 0000936728
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24006
FILM NUMBER: 231267584
MAIL ADDRESS:
STREET 1: C/O INCYTE CORPORATION
STREET 2: 3160 PORTER DRIVE
CITY: PALO ALTO
STATE: CA
ZIP: 93404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEKTAR THERAPEUTICS
CENTRAL INDEX KEY: 0000906709
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943134940
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 455 MISSION BAY BOULEVARD SOUTH
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 4154825300
MAIL ADDRESS:
STREET 1: 455 MISSION BAY BOULEVARD SOUTH
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
FORMER COMPANY:
FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS INC
DATE OF NAME CHANGE: 19980723
FORMER COMPANY:
FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS
DATE OF NAME CHANGE: 19940303
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-09-19
0
0000906709
NEKTAR THERAPEUTICS
NKTR
0000936728
WHITFIELD ROY A
C/O NEKTAR THERAPEUTICS
455 MISSION BAY BOULEVARD SOUTH
SAN FRANCISCO
CA
94158
1
0
0
0
0
Stock Option
0.68
2023-09-19
4
A
0
85000
0.00
A
2031-09-18
Common Stock
85000
85000
D
This stock option vests in equal monthly installments over the one-year period beginning on September 19, 2023.
Mark A. Wilson, Attorney-in-Fact
2023-09-20